BRIEF-Yichang HEC Changjiang Pharmaceutical gets clinical approvals from CFDA

May 4 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co

Ltd

* Clinical approvals successfully obtained from CFDA for

insulin aspart drug substance and product

Source text for Eikon:

Further company coverage: